Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection - The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial

被引:542
作者
Markus, HS
Droste, DW
Kaps, M
Larrue, V
Lees, KR
Siebler, M
Ringelstein, EB
机构
[1] St George Hosp, Sch Med, Dept Clin Neurosci, London SW17 0RE, England
[2] Ctr Hosp Luxembourg, Serv Neurol, Luxembourg, Luxembourg
[3] Univ Munster, Neurol Klin & Poliklin, D-4400 Munster, Germany
[4] Univ Giessen, Dept Neurol, Giessen, Germany
[5] Univ Toulouse, Dept Neurol, Toulouse, France
[6] Univ Glasgow, Glasgow, Lanark, Scotland
[7] Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut,Acute Stroke Unit, Glasgow G11 6NT, Lanark, Scotland
[8] Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut,Cerebrovasc Clin, Glasgow G11 6NT, Lanark, Scotland
[9] Univ Dusseldorf, Neurol Klin, D-4000 Dusseldorf, Germany
关键词
trials; embolism; stroke; ultrasonics; carotid arteries;
D O I
10.1161/01.CIR.0000163561.90680.1C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Evidence for efficacy of dual antiplatelet therapy in stroke is limited. Symptomatic carotid stenosis patients are at high risk of early recurrent stroke. In this group, asymptomatic microembolic signals (MES), detected by transcranial Doppler ultrasound (TCD), are markers of future stroke and transient ischemic attack (TIA) risk. They offer a surrogate marker to evaluate antiplatelet therapy, but no multicenter study has evaluated the feasibility of this approach. Methods and Results-Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) is a randomized, double-blind study in subjects with recently symptomatic >= 50% carotid stenosis. Patients were screened with TCD, and if MES were detected, they were randomized to clopidogrel and aspirin or aspirin monotherapy. Repeated TCD recordings were made on days 2 and 7. MES were detected in 110 of 230 patients by online analysis at baseline, of whom 107 were randomized. Intention-to-treat analysis revealed a significant reduction in the primary end point: 43.8% of dual-therapy patients were MES positive on day 7, as compared with 72.7% of monotherapy patients ( relative risk reduction 39.8%; 95% CI, 13.8 to 58.0; P = 0.0046). The secondary end point of MES frequency per hour was reduced (compared with baseline) by 61.4% (95% CI, 31.6 to 78.2; P = 0.0013) in the dual-therapy group at day 7 and by 61.6% (95% CI, 34.9 to 77.4; P = 0.0005) on day 2. There were 4 recurrent strokes and 7 TIAs in the monotherapy group versus no stroke and 4 TIAs in the dual-therapy group that were treatment emergent and ipsilateral to the qualifying carotid stenosis; 2 additional ipsilateral TIAs occurred before treatment started. MES frequency was greater in the 17 patients with recurrent ipsilateral events compared with the 90 without (mean +/- SD: 24.4 +/- 27.7 versus 8.9 +/- 11.5 per hour; P = 0.0003). Conclusions-In patients with recently symptomatic carotid stenosis, combination therapy with clopidogrel and aspirin is more effective than aspirin alone in reducing asymptomatic embolization. Doppler MES detection is a feasible method to evaluate the efficacy of antiplatelet therapy in multicenter studies.
引用
收藏
页码:2233 / 2240
页数:8
相关论文
共 39 条
  • [1] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [2] Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
    Bertrand, ME
    Rupprecht, HJ
    Urban, P
    Gershlick, AH
    [J]. CIRCULATION, 2000, 102 (06) : 624 - 629
  • [3] BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
  • [4] Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
    Cadroy, Y
    Bossavy, JP
    Thalamas, C
    Sagnard, L
    Sakariassen, K
    Boneu, B
    [J]. CIRCULATION, 2000, 101 (24) : 2823 - 2828
  • [5] Doppler microembolic signals predict ischemic recurrences in symptomatic carotid stenosis
    Censori, B
    Partziguian, T
    Casto, L
    Camerlingo, M
    Mamoli, A
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (05): : 327 - 331
  • [6] Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services
    Coull, AJ
    Lovett, JK
    Rothwell, PM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7435): : 326 - 328
  • [7] DAVID A, 2004, CIRCULATION, V109, P1476
  • [8] QUANTIFICATION OF ATHEROMATOUS STENOSIS IN THE EXTRACRANIAL INTERNAL CAROTID-ARTERY
    DEBRAY, JM
    GLATT, B
    [J]. CEREBROVASCULAR DISEASES, 1995, 5 (06) : 414 - 426
  • [9] Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    Diener, HC
    Bogousslavsky, J
    Brass, LM
    Cimminiello, C
    Csiba, L
    Kaste, M
    Leys, D
    Matias-Guiv, J
    Rupprecht, HJ
    [J]. LANCET, 2004, 364 (9431) : 331 - 337
  • [10] European stroke prevention study .2. Efficacy and safety data - Introduction
    Diener, HC
    Forbes, C
    Riekkinen, PJ
    Sivenius, J
    Smets, P
    Lowenthal, A
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 151 : S1 - +